Fáilte chuig an Institiúid um Leigheas Athghiniúnach
Welcome to the Regenerative Medicine Institute (REMEDI®)

Dr. Sean Dinneen

Consultant Endocrinologist
+353 91 525290

Consultant Endocrinologist, Galway University Hospitals

Interests are delivering programmes of self-management education for people with diabetes and developing optimal models of community-based diabetes care.

Researcher in

Research Project Area: 

Developing optimal models for community-based diabetes care: this has been a major focus of Dr Dinneen’s work both at the Mayo Clinic and in Addenbrooke’s. Dr Dinneen, with the help of Sue Holmes, a GP with a special interest in diabetes, have produced a robust (and continuously updated) set of diabetes clinical practice guidelines for Southern Cambridgeshire. Using community-based diabetes specialist nurses they have introduced a number of different approaches to community-based care in the locality.

The role of Information Technology in Diabetes Care: to properly integrate care between the hospital and the community requires knowledge of the entire population of people with diabetes and the ability to share information easily across interfaces. Dr Dinneen was involved in the implementation of a clinical information system in Addenbrooke’s was awarded 3 rd place (and £10,000) in the Trust’s 2003/4 Outstanding Achievement Awards.

Self-management education programmes for people with diabetes: Dr Dinneen’s involvement with the Dose Adjustment for Normal Eating (DAFNE) programme has been the most professionally rewarding work of his career. The principles of Therapeutic Patient Education, expounded originally by Jean-Phillipe Assal remain a professional mantra for him. Dr Dinneen was involved in the implementation of DAFNE in Addenbrooke’s and was recognised in a 2002/3 Outstanding Achievement Award. He is currently involved in the implementation and evaluation of the Irish DAFNE Study and a new model of ongoing care for people with type 1 diabetes, http://www.controlled-trials.com/ISRCTN79759174. Dr Dinneen is also a member of the Expert Advisory Group for Diabetes of the Health Service Executive. This is a 20 member group convened by the CEO to advise on all aspects of diabetes care delivery in Ireland. He is a member of the Standards of Care, Rethinopathy and Education/ Patient Empowerment sub-groups.

Leadership and Teamwork: these are key components of good diabetes care. Dr Dinneen has been fortunate to work with and to lead a number of very effective teams. The Addenbrooke’s Foot Team and the Southern Cambridgeshire Community Diabetes Team were both acknowledged by Addenbrooke’s Hospital and given “Over and Above” awards in 2004.

Positions Held: 

Dr Seán Dinneen received his medical degree from University College Cork Medical School. He undertook postgraduate training in medicine in Ireland and then went to the United States where he trained in Diabetes and Endocrinology at the Mayo Clinic. After a period on staff at the Mayo Clinic he was appointed as a Community Diabetologist in Addenbrooke’s Hospital, Cambridge. He spent 5 years working in the NHS before returning to Ireland in 2005 to take up a Senior Lecturer post in Medicine in Galway University Hospitals.

Awards & Honours: 

2004   "Over and Above” Award, Addenbrooke's Hospital Foot Team &  Southern Cambridgeshire Community Diabetes, Team, UK 

2002/2003  Outstanding Achievement Award, DAFNE Programme, Addenbrooke's Hospital, Cambridge, UK

Selected Publications: 

O'Loughlin A, McIntosh C, Dinneen SF, O'Brien T.  Review paper: basic concepts to novel therapies: a review of the diabetic foot.  Int J Low Extrem Wounds. 2010 Jun;9(2):90-102. Review.

Dinneen, S F., O' Hara, M C., Byrne, M., Newell, J., Daly, L., O' Shea, D., Smith, D., and Irish DAFNE Study Group. The Irish DAFNE Study Protocol: A cluster randomised trial of group versus individual follow-up after structured education for Type 1 diabetes. Trials 2009, 10:88

Glynn, L G., Buckley, B., Reddan, D., Newell, J., Hinde, J., Dinneen, S F., Murphy, A W. Multimorbidity and risk among patients with established cardiovascular disease: a cohort study. British Journal of General Practice. 58(552):488-94, 2008 Jul.

Hartweg J, Perera R, Montori V, Dinneen S, Neil HAW, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.:CD003205. DOI: 10.1002/14651858.CD003205.pub2.

Palmer AJ, Dinneen S, Gavin JR III, Gray A, Herman WH, Karter AJ. Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes. Curr Med Res Opin 2006;22:861-72.

Sarker A, Semple RK, Dinneen SF, O’Rahilly S, Martin SC. Severe hypoalphalipoproteinemia during treatment with rosiglitazone. Diabetes Care 2004;27:2577-80.

Yuyun MF, Dinneen SF, Edwards OM, Wood E, Wareham NJ. Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. Diabet Med 2003;20:277-282.

 Halvatsiotis PG, Turk D, Alzaid A, Dinneen S, Rizza RA, Nair KS. Insulin effect on leucine kinetics in type 2 diabetes mellitus. Diabetes Nutr Metab 2002; 15:136-42

Gerstein HC, Mann JFE, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce, Nawaz S, Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-426


Research Funding: 

Principal Investigator on “The West of Ireland Diabetes Foot Study: Epidemiology, cost, feasibility and implications for clinical practice and policy”. Funded by the Diabetes Federation of Ireland and Medical Research Charities Group in conjunction with the Health Research Board; €217,571 over 3 years.

Co-Investigator on “Patient Monitoring and Feedback Mechanism for Neuropathic Feet”. PI is Dr Martin Glavin, Department of Electronic Engineering, NUI, Galway. Funded by Enterprise Ireland Commercialisation Fund Proof of Concept Phase 2007

Co-Investigator for “Towards a national diabetes register for Ireland: theory, practice and policy”, PI is Prof Colin Bradley, Department of General Practice, UCC. Funded by the Health Research Board’s Health Services R&D Awards 2006. Total award €932,480; NUI, Galway allocation €96,483 over 4 years.

Principal Investigator on “Implementing and evaluating a structured education programme and a new model of ongoing care for Type 1 diabetes: the Irish DAFNE Study”. Funded in March 2005 by the Health Research Board’s Health Services R&D Awards; 1.2 million Euro over 5 years.

Co-Investigator on “Use of a diabetes electronic management system (DIAMOND) to support a shared care diabetes programme in Galway”. Funded in 2005 by the Health Research Board Infrastructure Grant.

Translation of Optimal Diabetes Care: from research to practice. This study is funded as part of a strategic alliance between the Division of Endocrinology, Mayo Clinic and Novo Nordisk Pharamaceuticals, Copenhagen, Denmark.

Search PubMed for Papers by Dr. Sean Dinneen >>